Phase III Gynecologic Oncology Group Study of Advanced Ovarian Cancer: Bevacizumab Added to Initial Chemotherapy Extends Progression-Free Survival
2009 ◽
Vol 115
(3)
◽
pp. 424-429
◽
2018 ◽
Vol 36
(15_suppl)
◽
pp. 5584-5584
2015 ◽
Vol 33
(15_suppl)
◽
pp. 5577-5577
2007 ◽
Vol 17
(1)
◽
pp. 1-20
◽
2004 ◽
Vol 2
(6)
◽
pp. 555-560
◽